|Bid||0.00 x 900|
|Ask||0.00 x 800|
|Day's Range||66.70 - 68.71|
|52 Week Range||44.87 - 68.71|
|Beta (3Y Monthly)||0.06|
|PE Ratio (TTM)||20.71|
|Earnings Date||Feb 4, 2019 - Feb 8, 2019|
|Forward Dividend & Yield||0.87 (1.30%)|
|1y Target Est||62.84|
Are you a shareholder of Baidu (NASDAQ:BIDU)? If so, you’re likely all too aware that Baidu stock is down 23% year to date. If you don’t own Baidu stock but are thinking of buying on the dip, might I suggest that you consider an alternative?
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. The rate of decline is significant relative to the trend shown over the past year, and is accelerating.
Church & Dwight is IBD Stock Of The Day as the consumer play works on a buy point despite the stock market being under pressure. The defensive stock's earnings are solid.
Church & Dwight (CHD) stock has risen 32.7% on a YTD basis due to the company’s strong financial performance in 2018. The company’s top and bottom line have grown at a phenomenal rate in 2018. Other major consumer packaged goods companies including Colgate-Palmolive (CL), Kimberly-Clark (KMB), and Procter & Gamble (PG) have struggled to lift their sales and EPS growth rate. Church & Dwight sustained the momentum during the third quarter, while the stock rose 11.55 in November.
Shares of major CPG (consumer packaged goods) manufacturers showed a healthy recovery in November and outperformed the benchmark index (SPX). Shares of Church & Dwight (CHD), Clorox (CLX), Kimberly-Clark (KMB), Procter & Gamble (PG), and Colgate-Palmolive (CL) increased 11.5%, 11.6%, 10.6%, 6.6%, and 6.7%, respectively, in November. In comparison, the S&P 500 Index increased 1.8% during the same period.
Colgate's (CL) dismal performance can be attributed to uncertain global markets. Also, a dismal sales trend is worrisome. However, the company's savings programs appear impressive.
P&G (PG) closes the acquisition of Merck KGaA's consumer-health business. This should bolster the company's OTC geographic scale, brand portfolio and category footprint.
Church & Dwight (CHD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
While the rest of the market struggles to get back up to records, a handful of consumer staples stocks have quietly rallied to new highs.
Wall Street analysts maintain a target price of $105.65 per share on Kimberly-Clark (KMB) stock, which indicates a downside of 8.5%, based on its closing price of $115.45 on November 27. Analysts expect Kimberly-Clark’s soft sales and weak margins to hurt its stock in the near term. Kimberly-Clark’s top line is expected to decline in the next couple of quarters, reflecting adverse currency rates and challenging market conditions in China.
Analysts expect Kimberly-Clark’s bottom line to take a hit from soft sales and cost headwinds in the near term. A higher tax rate is likely to affect the 2019 EPS growth rate. Analysts expect Kimberly-Clark to report adjusted earnings of $1.66 per share in the fourth quarter of 2018, which reflects year-over-year or YoY growth of 5.7%.
Kimberly-Clark’s (KMB) profit margins remained weak in the first nine months of 2018, and the trend is likely to continue as challenges persist, at least in the near term. Kimberly-Clark’s management expects inflation in commodities, including pulp and other raw materials, to continue to hurt its gross margins despite the benefits from a favorable mix, higher pricing, and cost savings. Weak gross margins are likely to hurt operating margins during the fourth quarter.
Wall Street expects Kimberly-Clark’s sales (KMB) to remain weak in the near term, at least over the next couple of quarters. Analysts expect Kimberly-Clark’s net sales to decline 2.7% in the fourth quarter of 2018. Meanwhile, its top line is forecast to fall 4.1% in the first quarter of 2019.
Church & Dwight's (CHD) consumer international business has been consistently contributing to organic sales growth. Additionally, its focus on buyouts is encouraging.
Clorox (CLX) benefits from its solid strategic efforts, including 2020 strategy, expansion of e-commerce capabilities and brand management initiatives.
A look at the shareholders of Church & Dwight Co Inc (NYSE:CHD) can tell us which group is most powerful. Generally speaking, as a company grows, institutions will increase their Read More...
Colgate-Palmolive’s (CL) unimpressive financial performance in the recent past and persisting challenges have led several analysts to lower their target price on Colgate-Palmolive stock. Moreover, SunTrust downgraded Colgate-Palmolive stock to “hold” from “buy” and reduced its target price to $65 per share from $80.
Colgate-Palmolive (CL) hasn’t impressed investors with its earnings in the past several quarters. The company has only surpassed analysts’ expectations in two quarters out of the past nine quarters, which is evident in the graph below. Soft sales and margin headwinds took a toll on the company’s bottom-line growth rate.
As for Colgate-Palmolive (CL), higher raw material and packaging costs more than offset the benefits from cost savings. Weak gross margin and higher SG&A expenses took a toll on its operating margin, which declined 20 basis points, 80 basis points, and 190 basis points in the first, second, and third quarter of 2018, respectively.
Colgate-Palmolive (CL) has been unable to impress investors with its sales performance so far this year. Though the company saw YoY improvement in net sales during the first two quarters of 2018, its net sales fell short of Wall Street’s expectations. Moreover, Colgate-Palmolive’s top line marked a YoY decline during the third quarter and also missed analysts’ expectation owing to challenges in Brazil and China coupled with adverse currency rates.
Colgate-Palmolive (CL) stock has unperformed so far this year as weaker-than-expected sales and sluggish performance on the margins front have remained a drag. Moreover, Colgate-Palmolive’s bottom line didn’t impress despite the lower tax environment.